Bryn Mawr Capital Management LLC Sells 27,339 Shares of Agilent Technologies, Inc. (NYSE:A)

Bryn Mawr Capital Management LLC lessened its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 80.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 6,649 shares of the medical research company's stock after selling 27,339 shares during the period. Bryn Mawr Capital Management LLC's holdings in Agilent Technologies were worth $893,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in A. CKW Financial Group raised its stake in shares of Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company's stock valued at $25,000 after purchasing an additional 100 shares in the last quarter. Global X Japan Co. Ltd. increased its holdings in Agilent Technologies by 161.1% in the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock valued at $25,000 after buying an additional 116 shares during the period. Ashton Thomas Securities LLC bought a new stake in Agilent Technologies in the 3rd quarter valued at $31,000. Fortitude Family Office LLC raised its stake in shares of Agilent Technologies by 68.3% in the 3rd quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company's stock valued at $35,000 after buying an additional 95 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC bought a new position in shares of Agilent Technologies during the 3rd quarter worth about $38,000. Institutional investors own 87.42% of the company's stock.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now owns 39,652 shares of the company's stock, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.26% of the company's stock.

Agilent Technologies Stock Performance

A traded down $1.46 during midday trading on Friday, reaching $135.33. The company had a trading volume of 1,112,236 shares, compared to its average volume of 1,641,125. Agilent Technologies, Inc. has a 12-month low of $124.16 and a 12-month high of $155.35. The business has a 50-day moving average price of $141.04 and a two-hundred day moving average price of $139.28. The stock has a market cap of $38.61 billion, a PE ratio of 30.62, a P/E/G ratio of 3.71 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.58 and a current ratio of 2.09.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share for the quarter, topping analysts' consensus estimates of $1.41 by $0.05. The firm had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The company's quarterly revenue was up .8% on a year-over-year basis. During the same quarter last year, the business earned $1.38 earnings per share. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be paid a $0.248 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.73%. Agilent Technologies's dividend payout ratio is currently 22.40%.

Analysts Set New Price Targets

A has been the topic of a number of analyst reports. Wells Fargo & Company lowered their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating on the stock in a research note on Monday, December 9th. StockNews.com upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Tuesday, December 24th. JPMorgan Chase & Co. cut their target price on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research report on Tuesday, November 26th. Barclays upgraded Agilent Technologies from an "underweight" rating to an "equal weight" rating and upped their price target for the company from $135.00 to $145.00 in a research report on Monday, February 10th. Finally, Citigroup increased their price objective on Agilent Technologies to $165.00 and gave the stock a "buy" rating in a research note on Thursday, December 19th. Seven analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Agilent Technologies currently has a consensus rating of "Moderate Buy" and a consensus target price of $144.38.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.